. Author manuscript; available in PMC: 2015 Aug 3.

Published in final edited form as: J Clin Apher. 2014 Oct 8;30(3):176–182. doi: 10.1002/jca.21360

TABLE I.

Patient and MM Pretransplant Characteristics

	Cy+G-CSF (n = 94)	G-CSF (n = 73)	P-value
Female gender, %	35	44	0.27
Median age at ASCT, years (range)	59 (34–76)	57 (33–73)	0.19
MM subtype, %			0.63
IgG	62	64
IgA	22	21
Light chain	14	15
Other	1	0
ISS Stage²⁰, %			0.39
I	48	56
II	28	30
III	21	14
Unknown*	3	0
Abnormal bone marrow cytogenetics or fluorescent in situ hydridization, %			0.09
No	51	55
Yes	19	29
Unknown^a	30	16

Totals of percentages may not equal 100% due to rounding.

ISS = International Staging System.

Unknown subjects were excluded from statistical analysis.